Skip to the page

Data / Drug companies / Hubei Gedian Humanwell Pharmaceutical Co., Ltd

Hubei Gedian Humanwell Pharmaceutical Co., Ltd: 35 products in the FDA NDC directory, labeler code 51508

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hubei Gedian Humanwell Pharmaceutical Co., Ltd (labeler code 51508) lists 35 products in the FDA National Drug Code Directory. By type: 35 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 23, 2026.

The request: Watch Hubei Gedian Humanwell Pharmaceutical Co., Ltd (FDA labeler code 51508): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51508
Products in commercial distribution
35
Packages
67
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
7
Earliest marketing start
July 12, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients35100%

Products by type

TypeProductsShare
Bulk ingredients35100%

Dosage forms

Dosage formProductsShare
Powder3497.1%
Cream12.9%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ethinylestradiol51508-217PowderBulk ingredientsOctober 23, 2026
Fluticasone propionate51508-216PowderBulk ingredientsOctober 20, 2026
Fluticasone furoate51508-215PowderBulk ingredientsOctober 20, 2026
Clascoterone51508-214PowderBulk ingredientsJuly 15, 2026
Eplerenone51508-213PowderBulk ingredientsApril 23, 2026
Medroxyprogesterone acetate51508-212PowderBulk ingredientsMarch 9, 2026
Drospirenone51508-211PowderBulk ingredientsMarch 9, 2026
Eslicarbazepine acetate51508-210PowderBulk ingredientsJune 13, 2025
Desonide51508-209CreamBulk ingredientsMay 9, 2025
Estradiol valerate51508-019PowderBulk ingredientsFebruary 17, 2025
Budesonide51508-208PowderBulk ingredientsNovember 19, 2024
Dutasteride51508-207PowderBulk ingredientsNovember 19, 2024
Finasteride51508-206PowderBulk ingredientsNovember 19, 2024
Levonorgestrel51508-203PowderBulk ingredientsNovember 19, 2024
Progesterone51508-202PowderBulk ingredientsNovember 19, 2024
Progesterone51508-201PowderBulk ingredientsNovember 19, 2024
Oxcarbazepine51508-205PowderBulk ingredientsNovember 18, 2024
Estradiol hemihydrate51508-204PowderBulk ingredientsNovember 15, 2024
Medroxyprogesterone acetate51508-017PowderBulk ingredientsApril 11, 2024
Estradiol51508-016PowderBulk ingredientsApril 11, 2024
Methylprednisolone hydrogen succinate51508-015PowderBulk ingredientsApril 11, 2024
Eslicarbazepine acetate51508-014PowderBulk ingredientsAugust 7, 2023
Drospirenone51508-013PowderBulk ingredientsMarch 9, 2022
Levonorgestrel51508-012PowderBulk ingredientsMarch 8, 2022
Mifepristone51508-011PowderBulk ingredientsMarch 4, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.